JANXJanux Therapeutics, Inc. Common Stock

CSNasdaq (XNAS)·USD

Identity

Security key: 17413
Ticker: JANX
Type: CS — Common Stock
Exchange: Nasdaq(XNAS)
Venue group: NASDAQ
Operating MIC: XNAS
Market: stocks
Locale: us
Currency: USD
Listed: 2021-06-11
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: JANX

Detail

Enriched 2026-08-14 20:47

Market cap: $1,019,150,005.91
Shares outstanding (class): 61,136,773
Shares outstanding (weighted): 61,136,773
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 113
Location: SAN DIEGO, CA
Homepage: https://www.januxrx.com
Description: Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Market cap and share counts drift.

Funds holding this security

95 funds · 95 positions · $106.19M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$19.80M	0.27%	1,424,540 NS	FIGI
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$17.04M	0.00%	1,225,837 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$14.63M	0.02%	1,052,539 NS	FIGI
Janus Henderson Global Life Sciences Fund JANUS INVESTMENT FUND	—	$10.01M	0.19%	720,074 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$7.53M	0.01%	541,795 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$5.89M	0.06%	423,646 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$5.45M	0.07%	392,349 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.42M	0.03%	246,138 NS	FIGI
VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS	—	$1.65M	0.07%	118,492 NS	FIGI
iShares Russell 2000 Growth ETF iShares Trust	IWO	$1.61M	0.01%	116,025 NS	FIGI
Allspring Common Stock Fund ALLSPRING FUNDS TRUST	—	$1.59M	0.28%	114,672 NS	FIGI
Small Cap Growth Stock Portfolio NORTHWESTERN MUTUAL SERIES FUND INC	—	$1.43M	0.19%	102,751 NS	FIGI
Nomura Healthcare Fund Delaware Group Equity Funds IV	—	$1.06M	0.16%	76,601 NS	FIGI
HARTFORD SMALL CAP GROWTH HLS FUND HARTFORD SERIES FUND INC	—	$1.03M	0.20%	74,279 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$1.02M	0.02%	73,409 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKERJANX
FIGI_COMPOSITEBBG00ZHSKH11
FIGI_SHARE_CLASSBBG00ZHSKH39
CIK0001817713
ISINUS47103J1051
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Common stock of a biopharmaceutical company classified under SIC 2834, indicating pharmaceutical preparations.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.